Immunome, Inc.
Pay Change, last update 1 day ago
Everything we hold on Immunome, Inc., newest first. Every line links to the filing or report it came from.
This profile is thin because we hold 2 source documents on Immunome, Inc. so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.
- 2026-08-15Pay Change Pay and benefits
Immunome, Inc. advertises a median posted salary band of $212,149 to $256,253 across 23 open roles
Advertised bands move before published pay data does, because they are set by what an employer thinks it must offer to fill a role today. Read the direction across postings rather than any one band, and remember this is the ask, not the settlement.
- 2025-12-31Pay Change Pay and benefits
Immunome, Inc.: $7,682,601 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
Immunome, Inc.: $9,226,774 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker